This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Parveen, Z. Articles by Pomerantz, R. J. Search for Related Content PubMed PubMed Citation Articles by Parveen, Z. Articles by Pomerantz, R. J.

 Previous Article  |  Next Article 

Journal of Virology, June 2004, p. 6480-6488, Vol. 78, No. 12
0022-538X/04/$08.00+0     DOI: 10.1128/JVI.78.12.6480-6488.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.

Cross-Packaging of Human Immunodeficiency Virus Type 1 Vector RNA by Spleen Necrosis Virus Proteins: Construction of a New Generation of Spleen Necrosis Virus-Derived Retroviral Vectors

Zahida Parveen,^1,2* Muhammad Mukhtar,^1,2 Adrienne Goodrich,^1,3 Edward Acheampong,^1,2 Ralph Dornburg,^1,2, and Roger J. Pomerantz^1,2*

The Dorrance H. Hamilton Laboratories, Center for Human Virology and Biodefense,¹ Division of Infectious Diseases and Environmental Medicine, Department of Medicine,² Department of Microbiology and Immunology, Thomas Jefferson University, Philadelphia, Pennsylvania 19107³

Received 11 December 2003/ Accepted 16 January 2004

The ability of the nonlentiviral retrovirus spleen necrosis virus (SNV) to cross-package the genomic RNA of the distantly related human immunodeficiency virus type 1 (HIV-1) and vice versa was analyzed. Such a model may allow us to further study HIV-1 replication and pathogenesis, as well as to develop safe gene therapy vectors. Our results suggest that SNV can cross-package HIV-1 genomic RNA but with lower efficiency than HIV-1 proteins. However, HIV-1-specific proteins were unable to cross-package SNV RNA. We also constructed SNV-based gag-pol chimeric variants by replacing the SNV integrase with the HIV-1 integrase, based on multiple sequence alignments and domain analyses. These analyses revealed that there are conserved domains in all retroviral integrase open reading frames (orf), despite the divergence in the primary sequences. The transcomplementation assays suggested that SNV proteins recognized one of the chimeric variants. This demonstrated that HIV-1 integrase is functional in the SNV gag-pol orf with a lower transduction efficiency, utilizing homologous (SNV) RNA, as well as the heterologous vector RNA of HIV-1. These findings suggest that homology in the conserved sequences of the integrase protein may not be fully competent in the replacement of protein(s) from one retrovirus to another, and there are likely several other factors involved in each of the steps related to replication, integration, and infection. However, further studies to dissect the gag-pol region will be critical for understanding the mechanisms involved in the cleavage of reverse transcriptase, RNase H, and integrase. These studies should provide further insight into the design and development of novel molecular approaches to block HIV-1 replication and to construct a new generation of SNV-based vectors.

This study is dedicated to the memory of Ralph Dornburg.

Deceased.